IQV News and Press, IQVIA Holdings Inc.

2024-06-25 10:29:34 ET More on S&P 500 Index: Odds For A Soft Landing Improve S&P 6300? Is That Outside The Realm Of Possibility? Nervous Calm Hangs Over The Markets Nasdaq, S&P, Dow are mixed after selloff in tech stocks Is the Nvidia-led...

IQVIA™ (NYSE:IQV), a leading global provider of AI-powered analytics, technology solutions, and clinical research services to the life sciences industry, today announced that the IQVIA SmartSolve Enterprise Quality Management System (eQMS) platform has been selected as the winner of the &#...

2024-06-23 20:39:26 ET Summary Harris Associates' 13F portfolio value increased from $58.03B to $61.82B this quarter, with around 200 positions reported. The top five stakes in the portfolio are Alphabet, IQVIA, Capital One Financial, Fiserv, and Intercontinental Exchange, totalin...

2024-06-22 14:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-06-20 10:50:09 ET More on iShares Russell 1000 Growth ETF: IWF: It Worked Well, But Is Vulnerable Going Forward Stocks with the highest swings in option premium price over 3 months - JPM Stocks with the least price swings, most attractive option-sale candidates ...

2024-06-12 15:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Bold initiative to boost the capacity of research sites enters Beta testing and piloting IQVIA (NYSE:IQV) today announced the launch of One Home for Sites™, a new technology platform that acts as a single sign-on and a single dashboard for the key systems and tasks a clinical res...

Cancer incidence is expected to rise significantly through 2050, particularly in lower-income countries, to 32 million new cases annually – a potential increase of more than 12 million new annual cases Global spending on cancer medicine increased to $223 billion in 2023, $25 billion mo...

2024-06-06 06:00:06 ET Matthew Sykes from Goldman Sachs issued a price target of $270.00 for IQV on 2024-06-06 04:43:00. The adjusted price target was set to $270.00. At the time of the announcement, IQV was trading at $218.9. The overall price target consensus is at $27...

2024-06-04 16:12:36 ET Summary Medpace Holdings is a US-based clinical research organization that is well-positioned to benefit from increased demand due to geopolitical risks affecting Chinese firms. Medpace stands out among its peers due to its growth orientation, competitive ma...